Logo image of CNP

CENTERPOINT ENERGY INC (CNP) Stock Fundamental Analysis

NYSE:CNP - US15189T1079 - Common Stock

37.94 USD
+0.23 (+0.61%)
Last: 9/2/2025, 8:04:00 PM
37.94 USD
0 (0%)
After Hours: 9/2/2025, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, CNP scores 2 out of 10 in our fundamental rating. CNP was compared to 25 industry peers in the Multi-Utilities industry. CNP has a medium profitability rating, but doesn't score so well on its financial health evaluation. CNP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CNP had positive earnings in the past year.
CNP had a positive operating cash flow in the past year.
Of the past 5 years CNP 4 years were profitable.
CNP had a positive operating cash flow in each of the past 5 years.
CNP Yearly Net Income VS EBIT VS OCF VS FCFCNP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B

1.2 Ratios

The Return On Assets of CNP (2.12%) is worse than 80.00% of its industry peers.
The Return On Equity of CNP (8.49%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 4.06%, CNP perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
CNP had an Average Return On Invested Capital over the past 3 years of 4.06%. This is in line with the industry average of 3.82%.
The 3 year average ROIC (4.06%) for CNP is below the current ROIC(4.06%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.12%
ROE 8.49%
ROIC 4.06%
ROA(3y)2.38%
ROA(5y)1.6%
ROE(3y)9.52%
ROE(5y)6.39%
ROIC(3y)4.06%
ROIC(5y)3.84%
CNP Yearly ROA, ROE, ROICCNP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

CNP has a Profit Margin of 10.42%. This is in the lower half of the industry: CNP underperforms 60.00% of its industry peers.
CNP's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 21.97%, CNP is in line with its industry, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CNP has grown nicely.
Industry RankSector Rank
OM 21.97%
PM (TTM) 10.42%
GM N/A
OM growth 3Y12.16%
OM growth 5Y10.21%
PM growth 3Y-10.88%
PM growth 5Y5.76%
GM growth 3YN/A
GM growth 5YN/A
CNP Yearly Profit, Operating, Gross MarginsCNP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

0

2. Health

2.1 Basic Checks

CNP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CNP has been increased compared to 1 year ago.
CNP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNP has a worse debt to assets ratio.
CNP Yearly Shares OutstandingCNP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CNP Yearly Total Debt VS Total AssetsCNP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

CNP has an Altman-Z score of 0.84. This is a bad value and indicates that CNP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.84, CNP is in line with its industry, outperforming 48.00% of the companies in the same industry.
CNP has a Debt/Equity ratio of 1.91. This is a high value indicating a heavy dependency on external financing.
CNP's Debt to Equity ratio of 1.91 is on the low side compared to the rest of the industry. CNP is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.63
WACC6.45%
CNP Yearly LT Debt VS Equity VS FCFCNP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B

2.3 Liquidity

CNP has a Current Ratio of 0.79. This is a bad value and indicates that CNP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CNP (0.79) is worse than 64.00% of its industry peers.
A Quick Ratio of 0.61 indicates that CNP may have some problems paying its short term obligations.
CNP has a Quick ratio (0.61) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.61
CNP Yearly Current Assets VS Current LiabilitesCNP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

CNP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.13%.
Measured over the past years, CNP shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.98% on average per year.
The Revenue has been growing slightly by 4.84% in the past year.
The Revenue has been growing slightly by 2.70% on average over the past years.
EPS 1Y (TTM)-6.13%
EPS 3Y-0.41%
EPS 5Y-1.98%
EPS Q2Q%-19.44%
Revenue 1Y (TTM)4.84%
Revenue growth 3Y1.15%
Revenue growth 5Y2.7%
Sales Q2Q%2.05%

3.2 Future

Based on estimates for the next years, CNP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.02% on average per year.
The Revenue is expected to grow by 5.19% on average over the next years.
EPS Next Y9.49%
EPS Next 2Y8.74%
EPS Next 3Y9.02%
EPS Next 5Y9.02%
Revenue Next Year1.76%
Revenue Next 2Y2.77%
Revenue Next 3Y3.38%
Revenue Next 5Y5.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNP Yearly Revenue VS EstimatesCNP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
CNP Yearly EPS VS EstimatesCNP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.80, which indicates a rather expensive current valuation of CNP.
Compared to the rest of the industry, the Price/Earnings ratio of CNP indicates a rather expensive valuation: CNP more expensive than 88.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.90, CNP is valued at the same level.
With a Price/Forward Earnings ratio of 19.80, CNP is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CNP is valued more expensive than 84.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.52. CNP is around the same levels.
Industry RankSector Rank
PE 24.8
Fwd PE 19.8
CNP Price Earnings VS Forward Price EarningsCNP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNP indicates a slightly more expensive valuation: CNP is more expensive than 64.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.04
CNP Per share dataCNP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.61
PEG (5Y)N/A
EPS Next 2Y8.74%
EPS Next 3Y9.02%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.35%, CNP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.67, CNP's dividend is way lower than its industry peers. On top of this 96.00% of the companies listed in the same industry pay a better dividend than CNP!
Compared to an average S&P500 Dividend Yield of 2.32, CNP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.35%

5.2 History

The dividend of CNP decreases each year by -10.10%.
CNP has paid a dividend for at least 10 years, which is a reliable track record.
CNP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-10.1%
Div Incr Years3
Div Non Decr Years3
CNP Yearly Dividends per shareCNP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

59.29% of the earnings are spent on dividend by CNP. This is a bit on the high side, but may be sustainable.
DP59.29%
EPS Next 2Y8.74%
EPS Next 3Y9.02%
CNP Yearly Income VS Free CF VS DividendCNP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
CNP Dividend Payout.CNP Dividend Payout, showing the Payout Ratio.CNP Dividend Payout.PayoutRetained Earnings

CENTERPOINT ENERGY INC

NYSE:CNP (9/2/2025, 8:04:00 PM)

After market: 37.94 0 (0%)

37.94

+0.23 (+0.61%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-27 2025-10-27/amc
Inst Owners106.49%
Inst Owner Change-0.35%
Ins Owners0.15%
Ins Owner Change2.86%
Market Cap24.77B
Analysts73.33
Price Target40.99 (8.04%)
Short Float %4.95%
Short Ratio6.26
Dividend
Industry RankSector Rank
Dividend Yield 2.35%
Yearly Dividend0.81
Dividend Growth(5Y)-10.1%
DP59.29%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-21 2025-08-21 (0.22)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.75%
Min EPS beat(2)-5.7%
Max EPS beat(2)-1.8%
EPS beat(4)0
Avg EPS beat(4)-2.96%
Min EPS beat(4)-5.7%
Max EPS beat(4)-1.37%
EPS beat(8)3
Avg EPS beat(8)1.57%
EPS beat(12)6
Avg EPS beat(12)1.82%
EPS beat(16)9
Avg EPS beat(16)4.74%
Revenue beat(2)2
Avg Revenue beat(2)6.34%
Min Revenue beat(2)2.32%
Max Revenue beat(2)10.36%
Revenue beat(4)2
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-9.77%
Max Revenue beat(4)10.36%
Revenue beat(8)2
Avg Revenue beat(8)-4.63%
Revenue beat(12)5
Avg Revenue beat(12)0.32%
Revenue beat(16)9
Avg Revenue beat(16)3.55%
PT rev (1m)2.96%
PT rev (3m)4.67%
EPS NQ rev (1m)-0.45%
EPS NQ rev (3m)1.72%
EPS NY rev (1m)0.36%
EPS NY rev (3m)0.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.24%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-2.35%
Valuation
Industry RankSector Rank
PE 24.8
Fwd PE 19.8
P/S 2.76
P/FCF N/A
P/OCF 12.42
P/B 2.25
P/tB 3.5
EV/EBITDA 13.04
EPS(TTM)1.53
EY4.03%
EPS(NY)1.92
Fwd EY5.05%
FCF(TTM)-5.18
FCFYN/A
OCF(TTM)3.06
OCFY8.05%
SpS13.76
BVpS16.88
TBVpS10.84
PEG (NY)2.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.12%
ROE 8.49%
ROCE 4.88%
ROIC 4.06%
ROICexc 4.14%
ROICexgc 4.59%
OM 21.97%
PM (TTM) 10.42%
GM N/A
FCFM N/A
ROA(3y)2.38%
ROA(5y)1.6%
ROE(3y)9.52%
ROE(5y)6.39%
ROIC(3y)4.06%
ROIC(5y)3.84%
ROICexc(3y)4.13%
ROICexc(5y)3.94%
ROICexgc(3y)4.67%
ROICexgc(5y)4.54%
ROCE(3y)4.87%
ROCE(5y)4.59%
ROICexcg growth 3Y3.86%
ROICexcg growth 5Y5.87%
ROICexc growth 3Y5.33%
ROICexc growth 5Y7.4%
OM growth 3Y12.16%
OM growth 5Y10.21%
PM growth 3Y-10.88%
PM growth 5Y5.76%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Debt/EBITDA 6.2
Cap/Depr 378.07%
Cap/Sales 59.9%
Interest Coverage 2.22
Cash Conversion 58.75%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.61
Altman-Z 0.84
F-Score3
WACC6.45%
ROIC/WACC0.63
Cap/Depr(3y)323.61%
Cap/Depr(5y)285.85%
Cap/Sales(3y)50.08%
Cap/Sales(5y)44.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.13%
EPS 3Y-0.41%
EPS 5Y-1.98%
EPS Q2Q%-19.44%
EPS Next Y9.49%
EPS Next 2Y8.74%
EPS Next 3Y9.02%
EPS Next 5Y9.02%
Revenue 1Y (TTM)4.84%
Revenue growth 3Y1.15%
Revenue growth 5Y2.7%
Sales Q2Q%2.05%
Revenue Next Year1.76%
Revenue Next 2Y2.77%
Revenue Next 3Y3.38%
Revenue Next 5Y5.19%
EBIT growth 1Y2.65%
EBIT growth 3Y13.45%
EBIT growth 5Y13.19%
EBIT Next Year87.69%
EBIT Next 3Y31.41%
EBIT Next 5Y23.69%
FCF growth 1Y-128.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.8%
OCF growth 3Y359.83%
OCF growth 5Y5.48%